What is the Optimal Duration of DAPT after PCI? Insights from the DAPT Trial - David Cohen, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Coronary - Antiplatelet Controversies for ACS: How Will They Impact Our Practice?

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$24.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

What is the Optimal Duration of DAPT after PCI? Insights from the DAPT Trial presented by David Cohen, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$24.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows

Session Name: Antiplatelet Controversies for ACS: How Will They Impact Our Practice?

Track: Coronary

Learning Objectives

  • Update in advances in ACS & AMI Management

Other Components in this Moment

Overview
How Does One Implement a Protocol for Antiplatelet Therapy in ACS and During PCI? - Jeffrey Berger, MD, MS
Why I Prefer Ticagrelor - Dominick Angiolillo, MD, PhD, FSCAI
Why I Prefer Prasugrel - Paul Gurbel, MD, FSCAI
Why I Prefer Clopidogrel – Medical or Economic? - David Cox, MD, FSCAI
Will I Start Using Cangrelor? - Gary Schaer, MD, FSCAI
Transition Care PostPCI: Is it Safe to Switch Back to Clopidogrel? - Paul Gurbel, MD, FSCAI
Should Tirofiban Alter Our Approach? - Michael Lipinski, MD, PhD, FSCAI
How Does Atrial Fibrillation Change the Equation - WOEST Protocol? - C. Michael Gibson, MD
What is the Optimal Duration of DAPT after PCI? Insights from the DAPT Trial - David Cohen, MD, FSCAI
How Vorapaxar Should be Integrated for ACS Patients in Practice - Ori Ben-Yehuda, MD
Dare to Say No: Are We Using Too Many Drugs? Can We Drop Aspirin? - Roxana Mehran, MD, FACC, FSCAI
Loading Simple Education